Skip to content

Effect of Fish Oil Supplement on Pregnancy Outcome in Women with a History of High-risk Pregnancy

Investigating the Effect of Fish Oil Supplement on Pregnancy Outcome in Women with a History of High-risk Pregnancy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20100701004281N3
Enrollment
200
Registered
2020-07-13
Start date
2015-03-30
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Increase of blood pressure during current pregnancy. Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

Interventions

Intervention 1: Intervention group: Soft capsule of 1000 mg salmon oil (Omega 3), without mercury, containing essential fatty acids (fish oil and flaxseed oil) made in Iran, Zahravi Pharmaceutical Com
Routine pregnancy care was also provided for this group. Intervention 2: Control group: No intervention was performed and they only received routine pregnancy care.

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Iranian race Age between 18 and 40 years Second pregnancy and after that History of problems such as preterm delivery; intrauterine growth retardation; preeclampsia; induced gestational hypertension in previous pregnancy The first visit to a medical center before the 16th week of pregnancy

Exclusion criteria

Exclusion criteria: Threat of miscarriage and placental abruption (bleeding) in the current pregnancy Cervical cerclage Having cardiovascular disease; kidney disease and lack of urinary tract infections; polyhydramnios; chronic lung disease; liver disease; hepatitis of any type; hyper and hypothyroidism; overt diabetes or gestational diabetes in previous pregnancies; diagnosis or suspicion of severe fetal abnormalities or hydrops in the current pregnancy Substance abuse, alcohol and smoking; regular consumption of fish oil or nonsteroidal anti-inflammatory agents or other medications Allergy to fish products Lack of desire to take pill and irregular visit

Design outcomes

Primary

MeasureTime frame
Newborn Weight. Timepoint: At birth time. Method of measurement: By means of newborns scale into gram.;Apgar score in the first and fifth minutes. Timepoint: At birth time. Method of measurement: Observation and physical examination.

Secondary

MeasureTime frame
Childbirth before 37 weeks. Timepoint: At the time of hospitalization. Method of measurement: Estimation of gestational age.;Increase of blood pressure. Timepoint: From the 16th week of pregnancy on prenatal visits. Method of measurement: By Blood pressure control device.;Mode of delivery. Timepoint: at birth time. Method of measurement: observation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahdieh Kiani

Shahroud University of Medical Sciences

kiani.m89@gmail.com+98 23 3239 5054

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026